Remarkably, and diametrically opposite to its role in disease maintenance, we observed that Ezh2 loss significantly accelerated the development of phenotypically identical MLL-AF9 and AML1-ETO9a AML (Fig. 3, b–d; and Fig. S4, d–i). This evidence concerns the gene RUNX1 and acute myeloid leukemia.